Mobile

A Multi-center, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Panel Study to Assess the Safety, Tolerability, and Glucose-Lowering Efficacy of MK-0893 in Patients With Type 2 Diabetes Melli...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-003869-17

A Multi-center, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Panel Study to Assess the Safety, Tolerability, and Glucose-Lowering Efficacy of MK-0893 in Patients With Type 2 Diabetes Mellitus

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Main objective: (1) To assess the effect of treatment with MK-0893 compared to placebo on 24-hour weighted mean glucose (WMG). (2) To assess the safety and tolerability of MK-0893.

Critère d'inclusion

  • Type II Diabetes

Liens